Detalles de la búsqueda
1.
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Signal Transduct Target Ther
; 7(1): 51, 2022 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35185150
2.
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Signal Transduct Target Ther
; 7(1): 110, 2022 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35365596
Resultados
1 -
2
de 2
1
Próxima >
>>